BioSpace News Archive

BioMidwest

Caron Receives Patents for Humanity COVID-19 Program Award from the United States Patent and Trademark Office

Caron Products and Services, Inc. (“Caron”) today announced the company has received the Patents for Humanity COVID-19 Program Award from the United States Patent and Trademark Office for their innovative vaporized hydrogen peroxide decontamination chamber to disinfect personal protection equipment (PPE).

January 25, 2023
·
3 min read
BioMidwest

Iaso Therapeutics Announces First Close in $1.25M Equity Series Seed Preferred Financing

Iaso Therapeutics, a Michigan State University startup developing novel technologies for next-generation vaccines, recently closed the first tranche of the company’s $1.25M Series Seed Preferred round of financing.

January 25, 2023
·
4 min read
Business

Nanomix Appoints Finance Veteran Chris Hetterly as Chief Financial Officer

Nanomix Corporation (OTCQB: NNMX) (“Nanomix” or the “Company”), a leader in mobile, affordable, point-of-care (POC) diagnostics, today announced the appointment of Christopher R. Hetterly as Chief Financial Officer (CFO).

January 25, 2023
·
3 min read
PreveCeutical - Australian Patent Granted for Disulfide Bond Containing Compounds

PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the “Company” or “PreveCeutical”), is pleased to announce the grant of Australian patent no. 2018305726, titled “Disulfide bond containing compounds and uses thereof,” on January 5, 2023.

January 25, 2023
·
5 min read
Deals

Phio Pharmaceuticals Announces Reverse-January 25, 2023 Stock Split

Phio Pharmaceuticals Corp. today announced that the Company’s Board of Directors has approved a reverse stock split of its shares of common stock.

January 25, 2023
·
5 min read
Genetown

Inhibikase Therapeutics Announces Publication Demonstrating Potential for c-Abl as a Key Therapeutic Target in Parkinson’s Disease and Related Disorders

Inhibikase Therapeutics, Inc. today announced the publication of studies describing the potential of IkT-148009 as a disease-modifying therapy for Parkinson’s disease and related disorders.

January 25, 2023
·
5 min read
Business

Outset Medical to Report Fourth Quarter and Full Year 2022 Financial Results on Monday, February 13, 2023

Outset Medical, Inc. today announced that it will release financial results for the fourth quarter and full year of 2022 after the close of trading on Monday, February 13, 2023.

January 25, 2023
·
1 min read
Biotech Bay

RenovoRx to Present at the Sequire Biotechnology Virtual Conference on February 2, 2023

RenovoRx, Inc. is scheduled to present virtually at the Sequire Biotechnology Conference on Thursday, February 2, 2023 at 4 p.m. (ET).

January 25, 2023
·
4 min read
Drug Development

Enlivex Announces Positive DSMB Recommendation and IMOH Clearance to Continue Phase I/II Trial of Allocetra in Patients with Advanced Solid Tumors

Enlivex Therapeutics Ltd. today announced that an independent Data and Safety Monitoring Board (DSMB) has completed its prespecified data review for the first cohort of patients in the Company’s ongoing Phase I/II cell therapy clinical trial of Allocetra TM in patients with advanced-stage solid tumors.

January 25, 2023
·
6 min read
Deals

Acasti Receives Extension to Regain Compliance with NASDAQ Minimum Bid Price Rule

Acasti Pharma Inc. announces that it has received notification from the NASDAQ Listing Qualifications Department (“NASDAQ”) that it is eligible for an additional 180 calendar days, or until July 24, 2023, to regain compliance with the minimum $1.00 per share requirement.

January 25, 2023
·
4 min read